ARTICLE | Company News
Aveo Pharmaceuticals, Novartis deal
August 24, 2015 7:00 AM UTC
Aveo granted Novartis exclusive, worldwide rights to develop and commercialize AV-380 and related antibodies targeting growth differentiation factor 15 (GDF15). Novartis also has a 90-day option to ...